The cure STARTs here.

START is dedicated to the conduct of Phase I Clinical Trials of novel
anticancer agents.

With centers located in San Antonio, Grand Rapids, Madrid, Shanghai, and Taipei, START conducts the world’s largest Phase I medical oncology program. Today, more than 50 percent of cancer patients can be cured with conventional treatments – that is, therapies with a proven response rate. However, there are many patients who do not respond to standard treatment and may be eligible for participation in our Phase I clinical trials program.

Preclinical Research

START is dedicated to developing improved preclinical models and assays to accelerate oncology drug development.

START's preclinical program is unique in that our researchers work alongside leading Phase I clinicians whose clinical experience and collaboration allows us to accelerate the movement of agents through preclinical development and into first in man studies. Contact Preclinical Services Now >

San Antonio 1000 Cancer Genome Project

START proudly supports the San Antonio 1000 Cancer Genome Project. Read more about how you can become involved.

More Information
START Center
Global 24-Hours Phase I Operations
San Antonio
Madrid
Shanghai

Lastest News

September 11th, 2017 FDA Grants Cemiplimab Breakthrough Designation for CSCC
December 8th, 2016 Texas Innovations in Health Care: START spreads clinical trials model abroad

START Madrid
The START Center for Cancer Care
The START Center for Cancer Care